Increasing rates of marijuana consumption highlights a need for research on the effects of smoking marijuana on the lungs.
Despite, marijuana being the most commonly smoked substance after tobacco and increasing rates of marijuana consumption have shown higher rates in respiratory related diseases, the extent of marijuana’s effect on the lungs are not well known.
A recent retrospective case-control study from the department of radiology, Ottawa Hospital General Campus, published in Radiology, found that marijuana smokers had higher rates of emphysema and airway inflammation changes than non-smokers and tobacco-only smokers.
“I can tell if someone is a heavy or a long-time cigarette smoker when I look at a CT scan,” Giselle Revah, MD, FRCPC, a radiologist at The Ottawa Hospital, where the research was conducted, said in a press release. “With marijuana being the second most inhaled substance after tobacco, I started wondering: What does marijuana inhalation look like on a CT scan? Would I be able to tell if someone was a marijuana smoker, is it different from cigarette smoke?”
Using chest CT examinations from October 2005 to July 2020, the investigators of this study compared rates of emphysema, air way changes, gynecomastia, and coronary artery calcification among a total of 56 marijuana smokers, 57 non-smokers, and 33 tobacco-only smokers. Age- and sex-matched subgroups were created for comparison in tobacco-only smokers older than 50 years.
Higher rates of emphysema were found in marijuana smokers (42 of 56 [76%]) than non-smokers (three of 57 [5%]) (P > .001), but not in tobacco-only smokers (22 of 33 [67%]) (P = .40). Emphysema rates were higher in aged-matched marijuana smokers (28 of 30 [93%]) than in tobacco-only smokers (22 of 33 [67%]) (P = .009).
Rates of airway changes, including bronchial thickening, bronchiectasis, and mucoid impaction were higher in marijuana smokers compared to other groups (P > .001 to P = .04). An age-matched subgroup analysis also showed higher rates of airway changes for marijuana smokers than tobacco-only smokers (P < .001 to P = .006).
Gynecomastia rates were also higher in marijuana smokers (13 of 34 [38%]) than in control patients (5 of 32 [16%]; P = .039), and in tobacco-only smokers (2 of 18 [11%]; P = .040).
There was no difference in coronary artery calcification rates among age-matched marijuana smokers (21 of 30 [70%] and tobacco-only smokers (28 of 33 [85%]) (P = .16).
The investigators suggest these findings may be related to the methods of inhalation that is different and uses longer held breath than tobacco smokers.
Furthermore, the investigators acknowledge certain limitations to their research, such as the small population sample size, its retrospective nature, and inconsistent quantification in the amount of marijuana use, due to its history of being an illegal possession.
Additionally, most marijuana smokers are also tobacco smokers, making it challenging to evaluate the effects of both marijuana and tobacco.
“We've identified an association between marijuana smoking and damage to both the small and the large airways,” Revah said. “We still need more research before we can affect policy change. We need larger, more robust prospective studies with more patients to confirm it.”
Reference
Murtha L, Sathiadoss P, Salameh J-P, Mcinnes MD, Revah G. Chest CT findings in marijuana smokers. Radiology. Published online November 15, 2022. doi:10.1148/radiol.212611
Consumers should not eat precut cantaloupe if they do not know the source, as the number of illnesses and recalls tied to a deadly salmonella outbreak grows; the White House and the Department of Education urged schools to take proactive steps to prevent youth drug use; a study published this week found a high prevalence of arrhythmia in patients with long COVID.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
Study Highlights BMP7 as a Potential Therapeutic Target for Ovarian Cancer
November 30th 2023High Bone Morphogenetic Protein 7 (BMP7) expression was significantly associated with aggressive phenotypes, including advanced grade, International Federation of Gynecology and Obstetrics stage, residual disease, and adverse overall survival.
Read More